Mostrar el registro sencillo

dc.contributor.authorGetino Redondo, María
dc.contributor.authorFernandez López, Raúl
dc.contributor.authorPalencia Gándara, Carolina
dc.contributor.authorCampos Gómez, Javier
dc.contributor.authorSánchez-López, Jose M.
dc.contributor.authorMartínez, Marta
dc.contributor.authorFernández, Antonio
dc.contributor.authorCruz Calahorra, Fernando de la 
dc.contributor.otherUniversidad de Cantabriaes_ES
dc.date.accessioned2022-02-17T18:34:06Z
dc.date.available2022-02-17T18:34:06Z
dc.date.issued2016
dc.identifier.issn1932-6203
dc.identifier.otherBFU2014-55534-C2-1-P
dc.identifier.urihttp://hdl.handle.net/10902/23983
dc.description.abstractBacterial conjugation is the main mechanism for the dissemination of multiple antibiotic resistance in human pathogens. This dissemination could be controlled by molecules that interfere with the conjugation process. A search for conjugation inhibitors among a collection of 1,632 natural compounds, identified tanzawaic acids A and B as best hits. They specially inhibited IncW and IncFII conjugative systems, including plasmids mobilized by them. Plasmids belonging to IncFI, IncI, IncL/M, IncX and IncH incompatibility groups were targeted to a lesser extent, whereas IncN and IncP plasmids were unaffected. Tanzawaic acids showed reduced toxicity in bacterial, fungal or human cells, when compared to synthetic conjugation inhibitors, opening the possibility of their deployment in complex environments, including natural settings relevant for antibiotic resistance dissemination.es_ES
dc.description.sponsorshipFunding: Work in the FDLC group was supported by grants BFU2014-55534-C2-1-P from the Spanish Ministry of Economy and Competitiveness (http://www.mineco.gob.es) and 612146/FP7-ICT-2013-10 and 282004/FP7-HEALTH-2011-2.3.1-2 from the European Seventh Framework Programme (https://ec.europa.eu/research/fp7). MG was supported by a PhD fellowship from the University of Cantabria (http://www.unican.es). JCG was supported by a postdoctoral fellowship ASTF 402-2010 from the European Molecular Biology Organization (http://www.embo.org). Biomar Microbial Technologies was supported by grant 282004/FP7-HEALTH-2011-2.3.1-2 from the European Seventh Framework Programme (https://ec.europa.eu/research/fp7). Biomar Microbial Technologies provided support in the form of salaries for authors JMSL, MM, and AF, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.es_ES
dc.format.extent13 p.es_ES
dc.language.isoenges_ES
dc.publisherPublic Library of Sciencees_ES
dc.rightsAttribution 4.0 Internationales_ES
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.sourcePLoS One . 2016 Jan 26;11(1):e0148098es_ES
dc.titleTanzawaic Acids, a Chemically Novel Set of Bacterial Conjugation Inhibitorses_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.relation.publisherVersionhttps://www.doi.org/10.1371/journal.pone.0148098es_ES
dc.rights.accessRightsopenAccesses_ES
dc.identifier.DOI10.1371/journal.pone.0148098
dc.type.versionpublishedVersiones_ES


Ficheros en el ítem

Thumbnail

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo

Attribution 4.0 InternationalExcepto si se señala otra cosa, la licencia del ítem se describe como Attribution 4.0 International